Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

103.00p
   
  • Change Today:
      2.60p
  • 52 Week High: 110.00p
  • 52 Week Low: 75.00p
  • Currency: UK Pounds
  • Shares Issued: 538.04m
  • Volume: 864,074
  • Market Cap: £554.19m
  • RiskGrade: 119
  • Beta: 0.20

Regulatory News

Total Voting Rights 01-Dec-2021 13:44 RNS
Director’s Dealing 22-Nov-2021 16:30 RNS
Update on Interim Dividend Timetable 09-Nov-2021 16:36 RNS
Total Voting Rights 01-Nov-2021 12:21 RNS
Total Voting Rights 04-Oct-2021 07:00 RNS
Grant of Options 01-Oct-2021 07:00 RNS
Interim Results 21-Sep-2021 07:00 RNS
Total Voting Rights 06-Sep-2021 11:19 RNS
Notification of Half Year Results 06-Sep-2021 07:00 RNS
Total Voting Rights 02-Aug-2021 14:44 RNS
Half Year Trading Update 20-Jul-2021 07:00 RNS
Block Listing Six Monthly Return 02-Jul-2021 10:28 RNS
Total Voting Rights 01-Jul-2021 16:06 RNS
Appointment of Non-Executive Director 29-Jun-2021 07:00 RNS
Notification of Major Holdings 02-Jun-2021 13:56 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 103.00p
Change Today 2.60p
% Change 2.59 %
52 Week High 110.00p
52 Week Low 75.00p
Volume 864,074
Shares Issued 538.04m
Market Cap £554.19m
Beta 0.20
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
85.8% below the market average85.8% below the market average85.8% below the market average85.8% below the market average85.8% below the market average
28.00% above the sector average28.00% above the sector average28.00% above the sector average28.00% above the sector average28.00% above the sector average
Price Trend
59.50% above the market average59.50% above the market average59.50% above the market average59.50% above the market average59.50% above the market average
30.00% above the sector average30.00% above the sector average30.00% above the sector average30.00% above the sector average30.00% above the sector average
Income
50% below the market average50% below the market average50% below the market average50% below the market average50% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Growth
13.07% below the market average13.07% below the market average13.07% below the market average13.07% below the market average13.07% below the market average
94.12% below the sector average94.12% below the sector average94.12% below the sector average94.12% below the sector average94.12% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 16-Dec-21 10-Jun-21
Paid 07-Jan-22 08-Jul-21
Amount 0.56p 1.07p

Trades for 03-Dec-2021

Time Volume / Share Price
16:37 150,000 @ 102.43p
16:37 150,000 @ 102.43p
16:40 16,675 @ 102.43p
16:35 156,651 @ 103.00p
16:29 18 @ 101.80p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page